top of page
QUATISE - Lab-to-Market Decision Intelligence Platform

APPLIED-RESEARCH-BASED DECISION-MAKING

Know what your
next move rests on.

QUATISE® connects evidence that is usually reviewed in separate silos, and derives second-order effects from it. This reveals which assumption matters, where the real constraint sits and what would justify the next commitment.

For innovation programmes, portfolios and science-based ventures.

Developed from original applied R&D certified under OECD Frascati Manual.

250+

Cases Assessed

(Strategy & Roadmap Development, Research for Decision-Making)

25+

Innovation Initiatives

(Active as Judge-Expert-Advisor, Speaker on Lab-to-Market Strategies)

€120M+

Capital Allocation Exposure

(Active Fundraising & Management, Advisory and Programme Evaluation)

USP

From interacting evidence to a defensible decision

QUATISE® examines how programme design, technology, adoption, capacity and capital affect one another. It tests which constraint limits the next move, what the evidence supports and which routes remain credible.

The result is a reasoned recommendation – with explicit conditions for continuing, adapting or stopping, and a clear basis for revisiting the decision.

Strong evidence in one area can hide a weak decision.

A successful pilot may prove the technology works. It may still leave open whether customers will pay, whether programme incentives reward the right behaviour, or whether the next investment removes the real bottleneck.

​

QUATISE® brings those questions into one judgement. The useful answer is not simply whether an idea looks promising. It is what has to be true for a particular commitment to make sense.

That gives you a reason you can explain today

– and a clear signal for when to reconsider.

Red-team recommendations & decisions before you invest

A decision is stronger when others can see its basis

and understand what could change it.

Find the constraint

See which unresolved condition limits

the next consequential move.

Trace the consequences

Understand how progress in one area

changes requirements elsewhere.

Choose the sequence

Put evidence, investment and implementation in an order

that reduces risks across lab-to-market journey.

Set the next gate

Know what would justify acting, waiting

or changing course.

Less guesswork at the point of commitment

QUATISE® reduces risks by making the weak link visible before it is carried into a funding, programme or growth decision.

WHAT QUATISE® ADDS

It identifies what limits
the next move.

QUATISE® tests the dependencies between evidence, adoption, incentives and capital. It identifies the condition that currently blocks progress, which action could remove it and what evidence would justify further commitment.

WHAT SEPARATE REVIEWS CAN SHOW

Strong parts, considered one by one.

Readiness scores, market studies and impact reports answer useful but separate questions. None of these answers alone establishes whether the parts can advance together.

✕

Readiness score: How developed?

✕

Impact report: What happened?

✓

QUATISE®: What can work next?

Original research.
Applied experience.
Independent advice.

The method combines an original research foundation with experience in the settings where these decisions have consequences.

RESEARCH

Developed from original work

The research underlying QUATISE® was formally recognised as applied R&D in Germany under OECD Frascati criteria.

PRACTICE

Applied across

real contexts

My work spans 25+ programmes and ecosystems, alongside 250+ venture and commercialisation assignments.

JUDGEMENT

Independent of the next sale

The recommendation serves your decision, including when the evidence supports changing course or delaying a commitment.

What would make your next commitment defensible?

Share the decision you face and the evidence already on the table. We can establish whether QUATISE® can reveal the critical dependency before you commit.

bottom of page